Ontology highlight
ABSTRACT:
SUBMITTER: Du Y
PROVIDER: S-EPMC7367613 | biostudies-literature | 2020 Jul
REPOSITORIES: biostudies-literature
Du Yingying Y Cao Qisheng Q Jiang Congqiao C Liang Hui H Ning Zhongliang Z Ji Chushu C Wang Jinguo J Zhou Chaoping C Jiang Zonghui Z Yu Changjun C Li Lei L Zhao Yong Y Xu Yuemei Y Xu Tengyun T Hu Wenjun W Wang Daoqin D Cheng Huaidong H Wang Guihe G Zhou Jinhua J Wang Song S Zhang Yanshun Y Hu Zhiqiang Z Li Xinzhong X Lu Donghui D Zhang Jun J Xie Hua H Sun Guoping G
Cancer medicine 20200522 14
Apatinib has been demonstrated to be effective and safe among patients with gastric cancer failing after at least two lines chemotherapy. This study aimed to evaluate its effectiveness and safety of low-dose apatinib for the treatment of gastric cancer in real-world practice. We performed a prospective, multicenter observation study in a real-world setting. Patients with advanced gastric cancer more than 18 years old were eligible and received low-dose apatinib (500 mg or 250mg per day) therapy. ...[more]